Allison Distler

479 total citations
12 papers, 167 citations indexed

About

Allison Distler is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Allison Distler has authored 12 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Allison Distler's work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (6 papers) and Ubiquitin and proteasome pathways (4 papers). Allison Distler is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (6 papers) and Ubiquitin and proteasome pathways (4 papers). Allison Distler collaborates with scholars based in United States and China. Allison Distler's co-authors include Susan Deng, Alejandro Villagra, John J. Powers, Javier Pinilla‐Ibarz, Eva Sahakian, Eduardo M. Sotomayor, Fengdong Cheng, Andressa L. Sodré, Jennifer Rock-Klotz and Je-In Youn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Leukocyte Biology.

In The Last Decade

Allison Distler

11 papers receiving 165 citations

Peers

Allison Distler

MB

IMMUN

ONCOL

HEMAT

CR

Teresa Preglej Austria

Marisa Mitchell-Flack United States

Nina Burgdorf France

Arman Öner Germany

Grace Ward United States

Erin R. Aho United States

M. Teresa Ciudad Canada

Sophia C. Mädler Germany

Patricia J. Ahl Singapore

Flavie Coquel France

Teresa Preglej Austria

Allison Distler

61 ×0.5

MB

55 ×0.8

IMMUN

37 ×0.6

ONCOL

7 ×0.6

HEMAT

8 ×1.0

CR

Citations per year, relative to Allison Distler Allison Distler (= 1×) peers Teresa Preglej

Countries citing papers authored by Allison Distler

Since Specialization

Citations

This map shows the geographic impact of Allison Distler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Distler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Distler more than expected).

Fields of papers citing papers by Allison Distler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Distler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Distler. The network helps show where Allison Distler may publish in the future.

Co-authorship network of co-authors of Allison Distler

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Distler. A scholar is included among the top collaborators of Allison Distler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Distler. Allison Distler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Mostofa, AGM, Allison Distler, Mark B. Meads, et al.. (2018). Functional Analysis of HDAC11 in Plasma Cell Development and Multiple Myeloma Survival. Blood. 132(Supplement 1). 3223–3223. 1 indexed citations

2.

Brayer, Jason, Allison Distler, Mark B. Meads, et al.. (2017). HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma. Blood. 130. 1800–1800. 1 indexed citations

3.

Distler, Allison, Jason Brayer, Mark B. Meads, et al.. (2017). HDAC11 as a candidate therapeutic target in multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). 8029–8029. 1 indexed citations

4.

Sahakian, Eva, Jie Chen, John J. Powers, et al.. (2017). Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology. Journal of Leukocyte Biology. 102(2). 475–486. 48 indexed citations

5.

Burger, Karen L., Mark B. Meads, Ariosto Silva, et al.. (2016). A CK1δ/CK1ε-to-Wnt/β-Catenin Circuit Is a Therapeutic Vulnerability in Primary and Drug Resistant Multiple Myeloma. Blood. 128(22). 2094–2094.

6.

Silva, Ariosto, Timothy Jacobson, Mark B. Meads, Allison Distler, & Kenneth H. Shain. (2015). An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells. Journal of Visualized Experiments. e53070–e53070. 13 indexed citations

7.

Shain, Kenneth H., Ariosto Silva, Mark B. Meads, et al.. (2015). A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma. Blood. 126(23). 501–501. 1 indexed citations

8.

Silva, Ariosto, Timothy Jacobson, Mark B. Meads, Allison Distler, & Kenneth H. Shain. (2015). An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells. Journal of Visualized Experiments. 3 indexed citations

9.

Sahakian, Eva, John J. Powers, Jie Chen, et al.. (2014). Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function. Molecular Immunology. 63(2). 579–585. 96 indexed citations

10.

Chen, Jie, Eva Sahakian, John J. Powers, et al.. (2014). Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition. Blood. 124(21). 225–225. 1 indexed citations

11.

Sahakian, Eva, Jason Brayer, John J. Powers, et al.. (2013). A Novel Role For Histone Deacetylase 11 (HDAC11) In Plasma Cell Differentation and Survival. Blood. 122(21). 1907–1907. 1 indexed citations

12.

Sahakian, Eva, John J. Powers, Jie Chen, et al.. (2013). A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis. Blood. 122(21). 2267–2267. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact